PBTS yields 181.82% · JNJ yields 2.14%● Live data
📍 PBTS pulled ahead of the other in Year 1
Combined, PBTS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PBTS + JNJ for your $10,000?
Powerbridge Technologies Co., Ltd. provides software application and technology solutions and services primarily in China. It offers Powerbridge System Solutions that include Trade Enterprise and Trade Compliance, as well as Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. The company also provides Powerbridge Software-as-a-Service solutions, which comprise Logistics Service Cloud and Trade Zone Operations Cloud, as well as Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan; and Powerbridge Blockchain-as-a-Service solutions that include Compliance Blockchain and Supply Chain Blockchain Services. It serves international trade businesses and manufacturers, government agencies and authorities, and logistics service and other providers. The company sells its solutions and services through its direct sales organization, indirect channel partners, and strategic government partners. Powerbridge Technologies Co., Ltd. was founded in 1997 and is headquartered in Zhuhai, China.
Full PBTS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.